McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
844.39
+0.13 (0.02%)
Nov 6, 2025, 12:34 PM EST - Market open
McKesson Employees
McKesson had 51,000 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
51,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,590,078
Profits / Employee
$79,078
Market Cap
105.03B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 51,000 | 0 | - |
| Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
| Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
| Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
| Mar 31, 2020 | 80,000 | 0 | - |
| Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
| Mar 31, 2018 | 78,000 | 0 | - |
| Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
| Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
| Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
| Mar 31, 2014 | 42,800 | -700 | -1.61% |
| Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
| Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
| Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
| Mar 31, 2010 | 32,500 | 0 | - |
| Mar 31, 2009 | 32,500 | -400 | -1.22% |
| Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
| Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
| Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
| Mar 31, 2005 | 25,200 | 600 | 2.44% |
| Mar 31, 2004 | 24,600 | 100 | 0.41% |
| Mar 31, 2003 | 24,500 | 500 | 2.08% |
| Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
| Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
| Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
| Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
| Mar 31, 1998 | 13,700 | 400 | 3.01% |
| Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
| Mar 31, 1996 | 11,300 | -900 | -7.38% |
| Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MCK News
- 17 hours ago - McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 19 hours ago - McKesson raises annual profit forecast on robust demand for specialty drugs - Reuters
- 20 hours ago - McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 7 days ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 20 days ago - Nike and 3 More Companies Raising the Alarm About Tariff Costs - Barrons
- 23 days ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons
- 26 days ago - McKesson Corporation Transforming Towards High-Margin Operations: Why I Choose To Buy - Seeking Alpha
- 26 days ago - McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity - Seeking Alpha